Alan M Garber Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Alan M Garber.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Alan M Garber. Alan M Garber is Director in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and Director in EXELIXIS, INC. ($EXEL).
Latest Insider Trading Transactions of Alan M Garber
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 28 2021 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Option Exercise | A | 22.48 | 33,549 | 754,182 | 33,549 | |
May 04 2021 | VRTX | VERTEX PHARMACEUTI ... | Garber Alan M | Director | Option Exercise | A | 217.20 | 6,067 | 1,317,752 | 6,067 | |
Mar 17 2021 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Option Exercise | M | 3.38 | 40,000 | 135,200 | 0 | |
Mar 17 2021 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Sell | S | 23.60 | 40,000 | 944,000 | 12,718 | 52.7 K to 12.7 K (-75.88 %) |
Mar 17 2021 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Buy | M | 3.38 | 40,000 | 135,200 | 52,718 | 12.7 K to 52.7 K (+314.51 %) |
Jun 03 2020 | VRTX | VERTEX PHARMACEUTI ... | Garber Alan M | Director | Option Exercise | A | 286.27 | 2,264 | 648,115 | 2,264 | |
Jun 03 2020 | VRTX | VERTEX PHARMACEUTI ... | Garber Alan M | Director | Grant | A | 0.00 | 699 | 0 | 5,890 | 5.2 K to 5.9 K (+13.47 %) |
May 22 2020 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Option Exercise | A | 24.62 | 30,750 | 757,065 | 30,750 | |
May 22 2020 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Option Exercise | A | 24.62 | 30,750 | 757,065 | 30,750 | |
May 22 2020 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Sell | S | 24.42 | 36,111 | 881,831 | 12,718 | 48.8 K to 12.7 K (-73.95 %) |
May 22 2020 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Sell | S | 24.42 | 36,111 | 881,831 | 12,718 | 48.8 K to 12.7 K (-73.95 %) |
Feb 14 2020 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Sell | S | 21.02 | 12,500 | 262,750 | 48,829 | 61.3 K to 48.8 K (-20.38 %) |
Jan 09 2020 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Option Exercise | M | 5.82 | 56,956 | 331,484 | 0 | |
Jan 09 2020 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Option Exercise | M | 4.58 | 30,000 | 137,400 | 0 | |
Jan 09 2020 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Sell | S | 18.01 | 86,956 | 1,566,078 | 61,329 | 148.3 K to 61.3 K (-58.64 %) |
Jan 09 2020 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Buy | M | 5.82 | 56,956 | 331,484 | 148,285 | 91.3 K to 148.3 K (+62.36 %) |
Jan 09 2020 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Buy | M | 4.58 | 30,000 | 137,400 | 91,329 | 61.3 K to 91.3 K (+48.92 %) |
Jun 04 2019 | VRTX | VERTEX PHARMACEUTI ... | Garber Alan M | Director | Option Exercise | A | 168.04 | 3,330 | 559,573 | 3,330 | |
Jun 04 2019 | VRTX | VERTEX PHARMACEUTI ... | Garber Alan M | Director | Grant | A | 0.00 | 1,191 | 0 | 5,191 | 4 K to 5.2 K (+29.78 %) |
May 24 2019 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Option Exercise | A | 19.77 | 42,641 | 843,013 | 42,641 | |
Apr 03 2019 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Option Exercise | S | 4.57 | 15,000 | 68,550 | 0 | |
Apr 03 2019 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Option Exercise | S | 5.92 | 15,000 | 88,800 | 0 | |
Apr 03 2019 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Sell | S | 23.97 | 15,000 | 359,550 | 61,329 | 76.3 K to 61.3 K (-19.65 %) |
Apr 03 2019 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Buy | M | 4.57 | 15,000 | 68,550 | 76,329 | 61.3 K to 76.3 K (+24.46 %) |
Apr 03 2019 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Sell | S | 24.00 | 15,000 | 360,000 | 61,329 | 76.3 K to 61.3 K (-19.65 %) |
Apr 03 2019 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Buy | M | 5.92 | 15,000 | 88,800 | 76,329 | 61.3 K to 76.3 K (+24.46 %) |
Jan 09 2019 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Option Exercise | M | 4.16 | 11,250 | 46,800 | 0 | |
Jan 09 2019 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Sell | S | 23.00 | 11,250 | 258,750 | 61,329 | 72.6 K to 61.3 K (-15.50 %) |
Jan 09 2019 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Buy | M | 4.16 | 11,250 | 46,800 | 72,579 | 61.3 K to 72.6 K (+18.34 %) |
Jun 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Garber Alan M | Director | Option Exercise | A | 152.74 | 3,229 | 493,197 | 3,229 | |
Jun 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Garber Alan M | Director | Grant | A | 0.00 | 1,801 | 0 | 4,000 | 2.2 K to 4 K (+81.90 %) |
May 24 2018 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Option Exercise | A | 20.50 | 31,167 | 638,924 | 31,167 | |
Apr 18 2018 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Option Exercise | M | 11.66 | 15,000 | 174,900 | 0 | |
Apr 18 2018 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Sell | S | 20.25 | 15,000 | 303,750 | 61,329 | 76.3 K to 61.3 K (-19.65 %) |
Apr 18 2018 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Buy | M | 11.66 | 15,000 | 174,900 | 76,329 | 61.3 K to 76.3 K (+24.46 %) |
Jan 10 2018 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Option Exercise | M | 7.97 | 11,500 | 91,655 | 0 | |
Jan 10 2018 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Option Exercise | M | 7.97 | 3,500 | 27,895 | 11,500 | |
Jan 10 2018 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Sell | S | 30.00 | 11,500 | 345,000 | 61,329 | 72.8 K to 61.3 K (-15.79 %) |
Jan 10 2018 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Buy | M | 7.97 | 11,500 | 91,655 | 72,829 | 61.3 K to 72.8 K (+18.75 %) |
Jan 10 2018 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Sell | S | 31.29 | 3,500 | 109,515 | 61,329 | 64.8 K to 61.3 K (-5.40 %) |
Jan 10 2018 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Buy | M | 7.97 | 3,500 | 27,895 | 64,829 | 61.3 K to 64.8 K (+5.71 %) |
Jun 09 2017 | VRTX | VERTEX PHARMACEUTI ... | Garber Alan M | Director | Option Exercise | M | 125.11 | 5,320 | 665,585 | 5,320 | |
Jun 09 2017 | VRTX | VERTEX PHARMACEUTI ... | Garber Alan M | Director | Grant | A | 0.00 | 2,199 | 0 | 2,199 | 0 to 2.2 K |
May 26 2017 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Option Exercise | A | 19.57 | 23,491 | 459,719 | 23,491 | |
Dec 09 2016 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Option Exercise | M | 10.53 | 10,000 | 105,300 | 0 | |
Dec 09 2016 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Sell | S | 16.90 | 7,832 | 132,361 | 61,329 | 69.2 K to 61.3 K (-11.32 %) |
Dec 09 2016 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Buy | M | 10.53 | 10,000 | 105,300 | 69,161 | 59.2 K to 69.2 K (+16.90 %) |
May 26 2016 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Option Exercise | A | 6.30 | 40,000 | 252,000 | 40,000 | |
Jan 05 2016 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Grant | A | 0.00 | 10,550 | 0 | 59,161 | 48.6 K to 59.2 K (+21.70 %) |
May 28 2015 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Option Exercise | A | 3.13 | 40,000 | 125,200 | 40,000 | |
May 20 2010 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Option Exercise | A | 5.92 | 15,000 | 88,800 | 15,000 | |
May 05 2008 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Option Exercise | A | 7.97 | 15,000 | 119,550 | 15,000 | |
May 03 2007 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Option Exercise | A | 10.53 | 10,000 | 105,300 | 10,000 | |
May 03 2006 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Option Exercise | A | 10.52 | 10,000 | 105,200 | 10,000 | |
Apr 25 2005 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Option Exercise | A | 7.13 | 10,000 | 71,300 | 10,000 | |
Jan 04 2005 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Option Exercise | A | 9.50 | 25,000 | 237,500 | 25,000 |
Page: 1